$4.69
5.39% yesterday
NYSE, May 20, 10:00 pm CET
ISIN
US34965K1079
Symbol
FTRE

Fortrea Stock price

$4.69
-0.51 9.81% 1M
-14.46 75.51% 6M
-13.96 74.85% YTD
-22.22 82.57% 1Y
-25.41 84.42% 3Y
-25.41 84.42% 5Y
-25.41 84.42% 10Y
NYSE, Closing price Tue, May 20 2025
+0.24 5.39%
ISIN
US34965K1079
Symbol
FTRE
Sector
Industry

Key metrics

Market capitalization $424.45m
Enterprise Value $1.61b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 11.09
EV/Sales (TTM) EV/Sales 0.60
P/S ratio (TTM) P/S ratio 0.16
P/B ratio (TTM) P/B ratio 0.49
Revenue growth (TTM) Revenue growth -10.69%
Revenue (TTM) Revenue $2.69b
EBIT (operating result TTM) EBIT $-102.50m
Free Cash Flow (TTM) Free Cash Flow $145.10m
Cash position $101.60m
EPS (TTM) EPS $-8.57
P/E forward negative
P/S forward 0.17
EV/Sales forward 0.64
Short interest 13.91%
Show more

Is Fortrea a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Fortrea Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Fortrea forecast:

1x Buy
7%
11x Hold
79%
2x Sell
14%

Analyst Opinions

14 Analysts have issued a Fortrea forecast:

Buy
7%
Hold
79%
Sell
14%

Financial data from Fortrea

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,686 2,686
11% 11%
100%
- Direct Costs 2,226 2,226
14% 14%
83%
460 460
14% 14%
17%
- Selling and Administrative Expenses 476 476
76% 76%
18%
- Research and Development Expense - -
-
-
-16 -16
112% 112%
-1%
- Depreciation and Amortization 86 86
21% 21%
3%
EBIT (Operating Income) EBIT -103 -103
493% 493%
-4%
Net Profit -771 -771
533% 533%
-29%

In millions USD.

Don't miss a Thing! We will send you all news about Fortrea directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fortrea Stock News

Neutral
Business Wire
8 days ago
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON FORTREA HOLDINGS INC. (FTRE), CLICK HERE TO INQUIRE ABO...
Neutral
Business Wire
8 days ago
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN FORTREA HOLDINGS INC. (FTRE), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUIN...
Neutral
Business Wire
8 days ago
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON FORTREA HOLDINGS INC. (FTRE), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YO...
More Fortrea News

Company Profile

Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. It operates under the Clinical Services and Enabling Services Segments. The Clinical Services segment provides services across the clinical pharmacology, clinical development, and other clinical service spectrum utilizing enabling services and technology through multiple delivery models. The Enabling Services segment provides technology solutions directly to customers that streamline complex randomization and optimize the trial drug supply process, while minimizing operational costs and supporting timely and accurate patient dosing. The company was founded on January 31, 2023 and is headquartered in Durham, NC.

Head office United States
CEO Peter Neupert
Employees 15,500
Founded 2023
Website fortrea.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today